Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (220K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lochrie, M. A.
Right arrow Articles by Polisky, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lochrie, M. A.
Right arrow Articles by Polisky, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 14 2902-2910, Copyright © 1997 by Oxford University Press


ARTICLES

In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein

MA Lochrie, S Waugh, DG Pratt Jr, J Clever, TG Parslow and B Polisky
NeXstar Pharmaceuticals, Inc., 2860 Wilderness Place, Boulder, CO 80301, USA. mlochrie@nexstar.com

RNA ligands that bind to the human immunodeficiency virus type-1 (HIV- 1) gag polyprotein with 10(-9) M affinity were isolated from a complex pool of RNAs using an in vitro selection method. The ligands bind to two different regions within gag, either to the matrix protein or to the nucleocapsid protein. Binding of a matrix ligand to gag did not interfere with the binding of a nucleocapsid ligand, and binding of a nucleocapsid ligand to gag did not interfere with the binding of a matrix ligand. However, binding of a nucleocapsid ligand to gag did interfere with binding of an RNA containing the HIV-1 RNA packaging element (psi), even though the sequence of the nucleocapsid ligand is not similar topsi. The minimal sequences required for the ligands to bind to matrix or nucleocapsid were determined. Minimal nucleocapsid ligands are predicted to form a stem-loop structure that has a self- complementary sequence at one end. Minimal matrix ligands are predicted to form a different stem-loop structure that has a CAARU loop sequence. The properties of these RNA ligands may provide tools for studying RNA interactions with matrix and nucleocapsid, and a novel method for inhibiting HIV replication.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
S. I. Jang, Y. H. Kim, S. Y. Paik, and J. C. You
Development of a Cell-Based Assay Probing the Specific Interaction between the Human Immunodeficiency Virus Type 1 Nucleocapsid and Psi RNA In Vivo
J. Virol., June 1, 2007; 81(11): 6151 - 6155.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
W. James
Aptamers in the virologists' toolkit
J. Gen. Virol., February 1, 2007; 88(2): 351 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. E. Ott, L. V. Coren, and T. D. Gagliardi
Redundant Roles for Nucleocapsid and Matrix RNA-Binding Sequences in Human Immunodeficiency Virus Type 1 Assembly
J. Virol., November 15, 2005; 79(22): 13839 - 13847.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Muriaux, S. Costes, K. Nagashima, J. Mirro, E. Cho, S. Lockett, and A. Rein
Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly
J. Virol., November 15, 2004; 78(22): 12378 - 12385.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
J.-M. LANCHY, J. D. IVANOVITCH, and J. S. LODMELL
A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA
RNA, August 1, 2003; 9(8): 1007 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Kemler, R. Barraza, and E. M. Poeschla
Mapping the Encapsidation Determinants of Feline Immunodeficiency Virus
J. Virol., October 25, 2002; 76(23): 11889 - 11903.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Clever, D. Miranda Jr., and T. G. Parslow
RNA Structure and Packaging Signals in the 5' Leader Region of the Human Immunodeficiency Virus Type 1 Genome
J. Virol., October 25, 2002; 76(23): 12381 - 12387.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Yu, S. M. Joshi, Y. M. Ma, R. L. Kingston, M. N. Simon, and V. M. Vogt
Characterization of Rous Sarcoma Virus Gag Particles Assembled In Vitro
J. Virol., March 15, 2001; 75(6): 2753 - 2764.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
N. A. Jewell and L. M. Mansky
In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly
J. Gen. Virol., August 1, 2000; 81(8): 1889 - 1899.
[Full Text]


Home page
J. Virol.Home page
J. L. Clever, R. A. Taplitz, M. A. Lochrie, B. Polisky, and T. G. Parslow
A Heterologous, High-Affinity RNA Ligand for Human Immunodeficiency Virus Gag Protein Has RNA Packaging Activity
J. Virol., January 1, 2000; 74(1): 541 - 546.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. T. Burniston, A. Cimarelli, J. Colgan, S. P. Curtis, and J. Luban
Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein
J. Virol., October 1, 1999; 73(10): 8527 - 8540.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. D. Jayasena
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Clin. Chem., September 1, 1999; 45(9): 1628 - 1650.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Helga-Maria, M.-L. Hammarskjöld, and D. Rekosh
An Intact TAR Element and Cytoplasmic Localization Are Necessary for Efficient Packaging of Human Immunodeficiency Virus Type 1 Genomic RNA
J. Virol., May 1, 1999; 73(5): 4127 - 4135.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
A. Bukrinskaya, B. Brichacek, A. Mann, and M. Stevenson
Establishment of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription Complex Involves the Cytoskeleton
J. Exp. Med., December 7, 1998; 188(11): 2113 - 2125.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.